Waldencast plc - SIC # 2840 -

Ticker Exchange SIC # Website Latest Ticker
WALD Nasdaq 2840 www.waldencast.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Waldencast plc

How Recent Developments Are Shaping the Waldencast Investment Story - Nov 29th, 2025 6:09 am
Here Are Tuesday’s Top Wall Street Analyst Research Calls: Applied Materials, CDW, Exact Sciences, Harley-Davidson, Oshkosh, ServiceNow and More - Nov 25th, 2025 7:17 am
Waldencast Announces Q2 2025 Results and Provides Q3 2025 Trading Update - Nov 24th, 2025 4:45 am
Obagi Medical Shares New Clinical Data on Obagi Hyaluronic Acid Injectables and Nu-Cil Scalp Serum at the 2025 American Society for Dermatologic Surgery Annual Meeting - Nov 15th, 2025 11:02 pm
Waldencast plc strengthens balance sheet position with the announcement of a trademark sale for Japan and refinancing of its credit facilities - Nov 14th, 2025 3:05 pm
Waldencast plc Provides Information Regarding Upcoming Earnings Release Dates - Nov 12th, 2025 5:33 am
Obagi Medical Launches Nu-Cil® BioStim™ Scalp Serum - Oct 8th, 2025 6:00 am
Why BeautyHealth (SKIN) Stock Is Trading Lower Today - Sep 10th, 2025 10:01 am
Waldencast Announces FDA Approval of Obagi® saypha® MagIQ™ Injectable Hyaluronic Acid Gel Under the Obagi Medical Brand - Sep 10th, 2025 4:45 am
Waldencast price target lowered to $3 from $4 at Telsey Advisory - Aug 21st, 2025 8:45 am
Waldencast Delays Earnings Release, Initiates Strategic Review Following Novaestiq Acquisition - Aug 19th, 2025 12:39 pm
Waldencast Announces Strong Progress on Business Priorities for H1 2025 and Initiatives to Drive Transformation - Aug 18th, 2025 3:43 pm
Waldencast plc (WALD) Acquired Novaestiq Corp. and the US Rights to the Saypha Line of Hyaluronic Acid Injectable Gels - Aug 11th, 2025 8:09 am
Gore Range Capital Announces Sale of Novaestiq Corp. to Waldencast - Jul 23rd, 2025 4:50 am
Waldencast Acquires Novaestiq Corp. and U.S. Rights to Leading Injectable Hyaluronic Acid Gel Line, Saypha®, Under the Obagi Medical Brand - Jul 23rd, 2025 4:45 am
Obagi, Milk Makeup Owner Waldencast Enters Filler Market With New Acquisition - Jul 23rd, 2025 4:45 am
Insiders with their considerable ownership were the key benefactors as Waldencast plc (NASDAQ:WALD) touches US$290m market cap - Jun 26th, 2025 5:47 am
Waldencast price target lowered to $4 from $5 at Telsey Advisory - May 16th, 2025 8:31 am
Waldencast Sees Improvement of 10 bps in Adjusted Gross Margin - May 13th, 2025 5:34 pm
Waldencast Reports Q1 2025 Financial Results - May 13th, 2025 2:15 pm